Roche Hit by Failure of Cancer Drug Trial
Roche said a late-stage study of its breast cancer drug Kadcyla
failed to yield superior results to an existing treatment, damaging
the outlook for stronger sales in one of its key drug markets.
Alstom CEO Says Talks With DOJ to Conclude Soon
Alstom Chief Executive Patrick Kron said that he expects talks
with the U.S. Department of Justice will reach a settlement "very
soon."
BlackBerry's Loss Narrows
BlackBerry posted a small fiscal 3Q operating profit and
achieved positive cash flow earlier than it had targeted. Revenue,
however, came in at $793 million, down about 34% from a year ago
and coming in below analyst views. Shares down 2% premarket.
American Reaches Deal With Flight Attendants
American Airlines Group said it had reached a joint
collective-bargaining deal with the union representing 24,000
flight attendants, clearing up one big area of uncertainty as it
continues its integration with US Airways.
Atos to Buy Xerox's IT Outsourcing Unit
Computer-services company Atos will buy Xerox's information
technology outsourcing business for $1.05 billion in cash, a deal
that would bolster the French company's position in the U.S.
BASF, Gazprom Call Off Asset Swap
Germany's BASF, the world's largest chemical company by revenue,
and Russia's OAO Gazprom have called off an asset-swap deal amid
mounting political tensions between Russia and the West.